TP53BP1 and acute myeloid leukemia: Notably, overexpression of DDX41 variants found in AML patients in either the DEAD (L237F/P238T) or helicase domain (R525H) resulted in the accumulation of 53BP1 foci in CD34+ cells (Fig. 6b).